We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
DIT Faculty of Pharmacy, Makkawala, Mussoorie Diversion Road, Dehradun-248009 India
Ocular inserts are sterile preparations, with a thin, multilayered, drug-impregnated, solid or semisolid consistency devices placed into cul-de-sac or conjunctiva sac. Ocular drug delivery is one of the most fascinating and challenging tasks facing the Pharmaceutical researchers. One of the major barriers of ocular medication is to obtain and maintain a therapeutic level at the site of action for prolonged period of time. Solvent casting technique was used to prepare the ocuserts. Ten formulation were prepared by using propranolol drug, cocos nucifera as biopolymer . The ocuserts were physically examined for colour and various other physical parameters were evaluated. Based on the physical parameters further studies were carried out like stability, invitro release studies. The therapeutic efficacy of an ocular drug can be greatly improved by prolonging its contact with the corneal surface. Newer ocular drug delivery systems are being explored to develop extended duration and controlled release strategy.
The eye as a portal for drug delivery is generally used for local therapy against systemic therapy in order to avoid the risk of eye damage from high blood con-centrations of the drug, which is not intended. The unique anatomy, physiology and biochemistry of the eye render this organ impervious to foreign substances, thus presenting a constant challenge to the formulator to circumvent the protective barriers of the eye without causing permanent tissue damage. Most ocular treatments like eye drops and suspen-sions call for the topical administration of ophthalmical-ly active drugs to the tissues around the ocular cavity. These dosage forms are easy to instill but suffer from the inherent drawback that the majority of the medication they contain is immediately diluted in the tear film as soon as the eye drop solution is instilled into the cul-de-sac and is rapidly drained away from the precorneal cavity by constant tear flow and lacrimo-nasal drainage. Therefore, only a very small fraction of the instilled dose is absorbed by the target tissue for this reason, concentrated solutions and frequent dosing are required for the instillation to achieve an adequate level of therapeutic effect. One of the new classes of drug delivery systems, ocular inserts, which are gaining worldwide praise, release drugs at a pre-programmed rate for a longer period by increasing the precorneal residence time Propranolol is a sympatholytic non-selective beta blocker. Sympatholytic are used to treat hypertension, anxiety and panic and glucoma. It was the first successful beta blocker developed. Propranolol is rapidly and completely absorbed, with peak plasma levels achieved approximately 1–3 hours after ingestion. The main metabolite 4-hydroxypropranolol, with a longer half-life (5.2–7.5 hours) than the parent compound (3–4 hours), is also pharmacologically active. Propranolol is a highly lipophilic drug achieving high concentrations in the brain. Propranolol is a non-selective beta blocker, that is, it blocks the action of epinephrine and norepinephrine on both β1- and β2-adrenergic receptors. It has little intrinsic sympathomimetic activity (ISA) but has strong membrane stabilizing activity. Coconut is highly nutritious and rich in fiber, vitamins, and minerals. It is classified as a "functional food" because it provides many health benefits beyond its nutritional content It is also a very good source of B-complex vitamins such as folates, riboflavin, niacin, thiamin, and pyridoxine. These vitamins are essential in the sense that body requires them from external sources to replenish. Coconut meat and water contain a very good amount of potassium. 100 g of fresh meat contains 356 mg% or 7.5% of daily required levels of potassium.
MATERIALS AND METHODS
Material- coconut bio-polymer were collected.
I. Preparation of Ocuserts
The various formulations of bio flexi ocusert were prepared by solvent casting method. Different bio-flexi ocusert (1:1 to 1:10) were prepared with varying concentration of the biopolymer. Biopolymer was taken in mortar pestle and triturated properly for the fine powder. After that 50 mg of dextrose & 50mg of glucose was added along with 100 mg of nanosized drug (propranolol). Then 10 ml of distill water was added and triturated properly in uniform direction. After that magnetic stirring was done for 45 minutes and sonication was performed (3cycle). After that the mixture was uniformly spreaded on a petri-dish and dried at room temperature. Bio-flexi film was obtained.
Formulation detail
|
formulation |
FB1 (1:1) |
FB2 (1:2) |
FB3 (1:3) |
FB4 (1:4) |
FB5 (1:5) |
FB6 (1:6) |
FB7 (1:7) |
FB8 (1:8) |
FB9 (1:9) |
FB9 (1:10) |
|
Propranolol(mg) |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
|
Cocos nucifera biopolymer |
1% |
2% |
3% |
4% |
5% |
6% |
7% |
8% |
9% |
10% |
|
dextrose |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
|
glucose |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
|
Distilled water |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
Flowchart-
|
10mg nanosized drug dispersed in distilled water |
|
Add 50mg of dextrose |
|
Keep on magnetic stirring for 10 mintand and sonication for 20 mint |
|
Makeup the volume upto 10mg with distilled water |
|
Spread it on petric dish for drying and bio flexi film scraped out |
|
Add 50mg of glucose and triturate it in mortor pestle |
|
Add 100 mg of biopolymer in different proportional with continuous stirring |
EVALUATION PARAMETER-
The ocuserts were evaluated for thickness, folding endurance, drug content uniformity, surface pH, and in-vitro diffusion studies
Thickness- Insert thickness was measured by a Vernier caliper at five different points on the film. The mean thickness and standard deviation (SD) were calculated.
|
Sr. No |
Formulation |
Thickness |
|
1 |
FC1 |
0.23 |
|
2 |
FC2 |
0.28 |
|
3 |
FC3 |
0.32 |
|
4 |
FC4 |
0.62 |
|
5 |
FC5 |
0.42 |
|
6 |
FC6 |
0.48 |
|
7 |
FC7 |
0.52 |
|
8 |
FC8 |
0.58 |
|
9 |
FC9 |
0.48 |
|
10 |
FC10 |
0.42 |
Weight uniformity - Weight uniformity of bio-flexi ocusert determined by taking weight of ten bio- flexi ocusert of sizes 1 square cm diameter from every batch and weight individually on electronic balance. The avg. weight was calculated.
|
S. No |
Formulation |
Weight Uniformity |
|
1 |
FC1 |
15.8 |
|
2 |
FC2 |
18.6 |
|
3 |
FC3 |
27.9 |
|
4 |
FC4 |
25.7 |
|
5 |
FC5 |
25.7 |
|
6 |
FC6 |
17.6 |
|
7 |
FC7 |
21.5 |
|
8 |
FC8 |
26.7 |
|
9 |
FC9 |
18.6 |
|
10 |
FC10 |
15.7 |
Folding Endurance- Folding Endurance of the film was determined by repeatedly folding the inserts at the same place till it breaks. The ocuserts was folded in the center, between finger and thumb and then opened. This was one folding. The number of times, the film could be folded at the same place without breaking gave the value of folding endurance
|
S.No |
Formulation |
Folding Indurance |
|
1 |
FC1 |
118 |
|
2 |
FC2 |
121 |
|
3 |
FC3 |
116 |
|
4 |
FC4 |
134 |
|
5 |
Deepika Kunwar*, Design and Evaluation of Propranolol Loaded Bio Flexi Ocusert Using Cocos Nucifera Biopolymer, Int. J. Med. Pharm. Sci., 2025, 1 (11), 157-161. https://doi.org/10.5281/zenodo.17694777 |